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COVID-19,	millions	 of	 dollars	 have	 been	 spent,	 hospitalization	 overstretched	with	
increasing	morbidity	and	mortality.	All	these	have	resulted	in	unprecedented	global	
economic	 catastrophe.	 Several	 drugs	 and	 vaccines	 are	 currently	 being	 evaluated,	



















blood-based	 dissemination	 affecting	 multiple	 organs,	 tissues,	 and	
blood	vessels	 (see	Figure	1).	Although,	most	 affected	patients	 die	
as	a	result	of	acute	respiratory	distress	syndrome.	Also,	several	or-
gans	including	the	liver,	hearts,	kidney,	muscles,	spleen,	and	nervous	
system are severely affected worsening prognostic outcomes initi-




men is yet to be established for disease prevention and or manage-
ment	 in	symptomatic	patients.	However,	drugs	such	as	remdesivir,	
lopinavir/ritonavir,	 favipiravir,	are	some	of	the	antiviral	agents	that	
have been used with varying degrees of successes in the manage-
ment	 of	 COVID-19	 (Wang	 et	 al.,	 2020).	 The	 intravenous	 adminis-
tration of remdesivir has been reported to ameliorate the disease 
symptoms	 in	 COVID-19	 patients	 in	 the	 United	 States	 of	 America	
(Holshue	 et	 al.,	 2020).	 Similarly,	 favipiravir	 has	 been	 reported	 to	
show	promising	desirable	therapeutic	effects,	without	apparent	side	
effects,	 in	COVID-19	(Chen	et	al.,	2020).	Furthermore,	tocilizumab	
(a	 recombinant	humanized	monoclonal	 antibody	of	 the	 IgG1	class)	
have been recommended for the treatment of severe rheumatoid 
arthritis,	systemic	juvenile	idiopathic	arthritis,	giant	cell	arteritis,	and	
life-threatening	cytokine	release	syndrome	(see	Figure	2).	Similarly,	
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skin,	and	only	0.1%	of	total	body	zinc	of	1µg/ml	is	found	in	plasma.	In	
extracellular	fluids,	zinc	is	predominantly	bound	to	proteins	includ-
ing	 albumin,	 alpha-2-macroglobulin	 (A2M),	 transferrin,	 and	 others	
(Livingstone,	2015).
The	intracellular	zinc	level	is	tightly	regulated	via	the	modulation	
of	 the	 zinc-sequestering	 proteins	 such	 as	metallothioneins,	 which	
are	 low	 molecular	 mass	 metal-binding	 protein	 of	 approximately	
6,500	Da	 that	 induces	 cytokine	 secretion	 from	macrophages.	The	
zinc	transporter	proteins	are	divided	into	two	general	subtypes,	that	
is,	 the	14-membered	SLC39s/ZIPs	 subtype	and	 the	10-membered	
SLC30s/ZnTs	subtype,	both	of	which	are	responsible	for	the	trans-
portation	of	 zinc	 intracellularly	 (Hojyo	&	Fukada,	2016).	The	ZnT1	
located	 in	 the	 cell	membrane	 transports	 zinc	 from	 the	basolateral	
membrane	of	erythrocytes	into	the	systemic	circulation,	while	ZnT2	
promotes	 the	 accumulation	 of	 zinc	 in	 lysosomes	 and	 endosomes	
thereby	ameliorating	toxic	cellular	effects	of	zinc.	The	ZnT3	is	found	
in	 the	 synaptic	 vesicles	 and	 is	 concerned	with	 zinc	 transportation	
to	synaptic	vesicles.	Furthermore,	ZnT4	modulates	zinc	absorption	
at the apical membrane of enterocytes and prominently involved in 
mammary	gland	zinc	metabolism.	However,	ZnT5	is	highly	expressed	
in pancreatic tissues but is found in other mammalian tissue where 
it	 plays	 several	modulatory	 roles,	 for	 instance,	 the	 loading	of	 zinc	
to	 alkaline	 phosphatase	 in	 secretory	 vesicles	 and	 maturation	 of	
osteoblasts	 in	 bone.	 ZnT6	 modulates	 the	 translocation	 of	 zinc	 to	








lactogenesis,	while	ZnT10	 transports	 zinc	 to	 secretory	vesicle	 and	
is	 reported	 to	be	highly	expressed	 in	various	 tissues	 including	 the	
brain	and	the	liver	(Baltaci	et	al.,	2017).	This	review	strengthens	the	
need for a global cooperative effort to urgently identify and develop 
effective therapeutic strategies in the absence of vaccine.
1.1 | Epidemiology
The	unprecedented	COVID-19	pandemic	is	caused	by	a	novel	RNA	
coronavirus	 called	 SARS-CoV-2	 that	 produces	 a	 severe	 acute	 res-
piratory	 distress	 syndrome	 (ARDS)	 (Gao	 et	 al.,	 2020).	 The	 SARS-
CoV-2	was	first	detected	in	Wuhan	province	of	China	in	December	
2019	 (14),	 and	 by	 March	 11	 2020,	 COVID-19	 was	 declared	 as	 a	
global	 pandemic	 by	World	 Health	 Organization	 (2020).	 This	 virus	
is	highly	infectious	with	a	high	prevalence	rate.	As	of	December	5,	
2020,	 66,000,000	 people	 have	 tested	 positive	 to	 the	 COVID-19	
with mortality rate of more than 1,520,000,	and	42,	400,	000	re-
covered	globally.	Presently	 in	Nigeria,	 there	are	more	than	68,627 
confirmed cases with over 1,179	deaths	due	to	COVID-19.	The	 in-




are	 in	 the	 last	 stage	 clinical	 trial,	 and	while	drugs	 currently	 in-use	







1.2 | Structure and genome of the SARS-CoV-2
The	family	Coronaviridae	is	a	large	group	of	viruses	that	infect	both	
animals	 and	 humans.	 The	 SARS-CoV-2	 is	 an	 enveloped	 virus	with	














CoV	 RaTH13	 with	 an	 estimated	 80%	 similarity	 with	 SARS-CoV-2	
(Gralinski	&	Menachery,	2020),	and	similarly	an	estimated	50%	iden-
tity	with	MERS-CoV	(Wu,	Peng,	et	al.,	2020;	Wu,	Liu,	et	al.,	2020).
1.3 | Possible mechanisms of Zinc in COVID-19-
related pathogenesis
Previous	 study	 suggested	 that	 ACE-2	 expression	 is	 regulated	 by	
Sirtuin	1	(SIRT1);	and	that	zinc	decreases	SIRT1	activity,	hence,	regu-








the	 respiratory	 tract	 (Roscioli	et	al.,	2017).	Moreover,	 zinc	 supple-
mentation has been reported to improve lung integrity in an in vivo 
murine	model	of	acute	lung	injury	(Wessels	et	al.,	2020).	Therefore,	
infections with coronaviruses has been reported to precipitate 
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damage	of	the	ciliated	epithelium	and	ciliary	dyskinesia	with	ultimate	
impairment	of	 the	mucociliar	 clearance	 (Chilvers	et	al.,	2001).	 It	 is	
particularly important to note that physiological concentrations of 










virus	 replication	by	 increasing	pH	 in	 intracellular	 vesicles	 and	also	
interfere	with	the	virus	entry	into	cells.	Again,	the	effectiveness	of	
zinc	can	be	enhanced	using	chloroquine	as	an	ionophore	while	zinc	
inside	 the	 infected	 cell	 can	 stop	 SARS-CoV-2	 replication	 (Rahman	
&	Idid,	2020).	In	addition	to	SARS-CoV,	a	number	of	other	viruses,	
including	HIV,	HSV,	 and	 vaccinia	 virus,	 are	 known	 to	 be	 inhibited	







also	shown	that	Zn2+ inhibited the proteolytic processing of repli-
case	polyproteins	(Celik	et	al.,	2020;	Mossink,	2020).





able	 for	 systemic	 use,	 also	 varies	 overwhelmingly.	 Interestingly,	 red	
meat,	leguminous	crops,	and	whole	grains	are	some	of	the	food	types	




intake	 of	 zinc	 has	 been	 characterized	 as	 zinc	 deficiency	 a	 common	
medical phenomenon particularly in the aged and patients consum-
ing	 meat-free	 diets	 (Haase	 et	 al.,	 2006).	 Although,	 diet-related	 zinc	




Clinically,	 absence	 of	 zinc	 in	 the	 diet	 may	manifest	 as	 altered	
reproductive	 functioning,	 severe	 immune	 dysfunctions	 leading	 to	
increased	susceptibility	to	infections,	hyperammonemia,	neurosen-
sory	 disorders,	 decreased	 lean	 body	 mass,	 diarrhea,	 skin	 lesions,	
stunted	 growth,	 and	 increased	 susceptibility	 to	 chronic	 noncom-
municable	 diseases	 (Prasad,	 2008).	Moreover,	 patients	 consuming	
zinc-deficient	diet	have	also	been	reported	to	suffer	from	thymic	and	
splenic atrophy. In utero,	adverse	effects	of	chronic	consumption	of	
zinc-deficient	diets	have	been	reported	to	include	high	rates	of	fetal	




reduced synthesis of collagen and proteoglycans in the presence of 
reduced	phosphatase	activity	(Tapiero	&	Tew,	2003).	In	addition	to	
inadequate	 dietary	 zinc	 intake,	 deficiency	 of	 zinc	may	 result	 from	
impaired	absorption	or	resorption	or	increased	excretion	of	zinc,	and	
several	 pathologic	 statuses	 including	 chronic	 diarrhea,	 extensive	
burns,	or	traumatic	and	surgical	wounds	(Aliev	et	al.,	2019).
Replenishing	 body	 zinc	 through	 adequate	 dietary	 intake	 is	 re-
quired	for	optimal	physiological	functioning	of	mammalian	organs	or	
tissues	due	to	the	non-availability	of	dedicated	storage	compartment	
for	 zinc	 and	 almost	 absolute	 reliance	 on	 tightly	 regulated	 homeo-
static	 concentrations	 (Gibson	 et	 al.,	 2016).	 Zinc	 is	 hydrophilic	 and	
cannot	diffuse	passively	through	the	cell	membrane.	As	a	result,	zinc	





to	be	 the	 function	of	ZIP5	which	 is	 largely	expressed	 in	 intestine,	
pancreas,	kidney,	and	embryonic	yolk	sac	(Jeong	&	Eide,	2013).	The	
zinc	 transporters	 function	 as	 zinc/hydrogen	 exchangers	 and	 play	
several important modulatory effects in diverse physiologic and 
pathologic	mechanisms	in	the	mammalian	systems	(Lu	et	al.,	2008).	




has	been	attributed	 to	 the	essentiality	of	 zinc	 to	 the	 formation	of	
several	endogenous	enzymatic	antioxidants	and	the	stabilization	of	




immune	 system	 response	 with	 consequent	 altered	 resistance	 to	




neuronal,	 cardiovascular	 systems,	 and	 wound	 healing	 (King	 et	 al.,	
2016;	Yu	et	al.,	2018).
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adequate	 zinc	 level	 is	 required	 for	 the	 activation	 of	 natural	 killer	
cells	(Baltaci	et	al.,	2018).	Furthermore,	the	number	and	functional	












patibility	complex	 (MHC)	by	natural	killer	 cells,	 and	 the	CD3+ dif-
ferentiation	and	cytotoxic	activity	has	been	reported	to	significantly	
increase	zinc	availability	(Jarosz	et	al.,	2017).
4  | ANTI- INFL AMMATORY ROLE OF ZINC
Several	cytokines	such	as	interleukins	1,	2,	6,	10,	and	12,	tumor	ne-
crosis	 factor	 alpha	 (TNFα),	 transforming	 growth	 factor	 (TGF),	 and	
interferon	gamma	(IFγ)	enhance	local	and	systemic	inflammatory	ef-
fects,	fever,	hormone	release,	and	increased	migration	of	leukocytes	
have been reported to be modulated by varying physiological levels 
of	zinc	in	mammalian	systems	(see	Figure	3).	Moreover,	zinc	has	been	
reported	to	inhibit	the	activation	of	nuclear	factor	kappa-light-chain-
enhancer	 of	 activated	B	 cells	 (NF-κB)	 in	 the	DNA	nuclear-binding	




molecule	 (see	Figure	3).	Consequently,	 the	 suppression	of	 the	 im-










Supplementation	 of	 zinc	 in	 diets	 has	 been	 reported	 to	 down-
regulate	 the	 production	 of	 inflammatory	 cytokines	 from	 T	 helper	
cells	 and	macrophages	probably	by	decreasing	gene	expression	of	
IL-1β	 and	TNF-α	 through	upregulation	of	mRNA	and	DNA-specific	
binding	 for	A20,	 subsequently	 inhibiting	NF-κB	 activation	 (Prasad	
et	 al.,	 2004).	 In	 in	 vitro	 studies,	 decreased	 levels	 of	 NF-κB,	 TNF-
α,	 and	 IL-1β	 are	 associated	with	 altered	 zinc	 levels	 (see	 Figure	 3).	
Similarly,	zinc	can	bind	to	a	zinc	 finger-like	motif	 found	on	protein	
kinase	C	(PKC)	and	inhibit	PMA-mediated	PKC	translocation	to	the	






     |  7 of 12OYAGBEMI Et Al.
membrane.	When	 this	 occurs	 in	mast	 cells,	NF-κB	activity	 is	 indi-
rectly	 inhibited	 (Brieger	 et	 al.,	 2013).	 Furthermore,	 zinc	 has	 been	
shown to influence cellular signal transduction by inhibition of sev-
eral	dephosphorylating	enzymes	 like	protein	tyrosine	phosphatase	
(PTPs),	 cyclic	 nucleotide	 phosphodiesterases,	 and	 dual	 specificity	
phosphatases.
5  | ZINC IN MANAGING COVID -19-
A SSOCIATED CY TOKINE STORM
Severe	 infection	 of	 the	 respiratory	 epithelium	 can	 precipitate	 an	
ARDS,	 characterized	 by	 excessive,	 exaggerated,	 and	 fulminating	
inflammation,	 termed	 a	 cytokine	 storm	 (Calder,	 2020).	 Cytokine	
storm	occurs	when	an	immune	system	is	overactivated	by	infection,	
drug,	and/or	some	other	stimuli,	leading	to	exaggerated	response	of	
cytokines	 (IFN,	 IL,	chemokines,	CSF,	TNF,	etc.)	being	released	 into	
circulation with a widespread and detrimental impact on multiple 
organs	 (Tisoncik	 et	 al.,	 2012).	 It	 has	 been	hypothesized	 that	 tran-
sient	 zinc	deficiency	 that	occurs	during	COVID-19	 infection	 could	
result	in	a	hyperinflammatory	state,	and	recently,	symptoms	such	as	





et	 al.,	 2020).	 Furthermore,	 high	 serum	 levels	 of	 pro-inflammatory	
cytokines	 [IL-1,	 IL-6,	 IL-12,	 interferon	 g	 (IFN-g),	 and	 transform-
ing	 growth	 factor-β]	 and	 chemokines	 (CCL2,	CXCL9,	CXCL10,	 and	
IL-8)	were	 found	 in	patients	with	SARS	compared	with	 individuals	
with	uncomplicated	SARS	(Martinez-Urbistondo	et	al.,	2020;	Wong	
et	 al.,	 2004).	 In	 mild	 diseases,	 C-reactive	 protein	 (CRP)	 levels	 of	
15	mg/L,	and	a	10%	decrease	in	zinc	was	observed	(Galloway	et	al.,	
2000).	 In	 severe	 infectious	 diseases,	 CRP	 levels	 can	 reach	 100–
200	mg/L,	with	a	much	greater	decrease	 in	zinc	 levels	 (40%–60%)	
(Galloway	et	al.,	2000).
Excessive	 inflammatory	 response	 elicited	 by	 SARS-CoV-2	 in-
fection	 has	 been	 found	 to	 result	 in	 the	 overproduction	 of	 pro-in-
flammatory	 cytokines	 and	 cytokine,	 and	 this	 is	 known	 to	 play	 a	
significant	 role	 in	COVID-19	pathogenesis	 (Patterson	et	al.,	2020).	
However,	 the	 anti-inflammatory	 activity	 of	 zinc	 has	 been	 demon-
strated	 through	 the	 regulation	of	T-cell	 function,	 inhibition	of	 IKK	
activity,	 and	 subsequent	NF-κB	 signaling	with	 concomitant	 reduc-
tion	in	pro-inflammatory	cytokine	production	(Wessels	et	al.,	2013).	
Previous	 findings	 demonstrated	 that	 zinc	 deficiency	 increases	 the	
susceptibility	 to	 systemic	 inflammation	 and	 sepsis-induced	 organ	
damage	including	lungs	(Knoell	et	al.,	2009).	Again,	Bao	et	al.	(2010)	
reported	 that	 in	a	model	of	multiple	 infection-induced	sepsis,	 zinc	







6  | ANTIOXIDANT PROPERTIES OF ZINC
Although	zinc	does	not	inhibit	the	destructive	effects	of	reactive	
oxygen	species	(ROS)	directly,	zinc	retards	the	oxidative	processes	
on	 a	 long-term	 basis	 by	 inducing	 the	 expression	 of	metallothio-
neins.	These	are	metal-binding	cysteine-rich	proteins	responsible	
for	 maintaining	 zinc-related	 cell	 homeostasis	 and	 act	 as	 potent	
electrophilic	scavengers	and	cytoprotective	agents.	Furthermore,	
zinc	increases	the	activation	of	antioxidant	proteins	and	enzymes,	














−	 radical	 into	 the	 less	 harmful	O2 and 
H2O2	(Mariani,	2008).
Zinc	potently	inhibits	the	Mia40/Erv1	pathway	associated	with	
the transmembrane immunoglobulin and mucin domain family pro-
teins	 that	 modulate	 T-cell	 proliferation	 and	 cytokine	 production	
(Morgan	et	al.,	2009).	Alteration	in	intracellular	zinc	level	has	been	
suggested	 to	 be	 linked	with	 the	 dysregulation	 of	 physiological	 ar-
rangement	of	mitochondrial	proteins,	thereby	interfering	with	mito-
chondrial	synthesis,	and	in	some	cases	activation	of	stress	response	
in the endoplasmic reticulum due to accumulation of misfolded pro-
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7  | ANTIVIR AL PROPERTIES OF ZINC
Zinc	 has	 been	 reported	 to	 exert	 potent	 antiviral	 activities	 against	
diverse	 array	 of	 viruses	 including	 the	 herpes	 simplex	 virus	 1	 and	
2,	 rhinovirus,	 influenza,	 coronaviruses,	 human	 immunodeficiency	
virus,	and	a	host	of	other	pathogenic	viruses.	Zinc	has	been	reported	
to	ameliorate	the	pathogenic	effects	of	HSV-1	and	HSV-2	by	alter-
ing	 the	 viral	 polymerase	 function,	 protein	 production,	 and	 direct	














lioration of clinical symptoms associated with common cold has been 
reported	to	occur	following	increased	level	of	zinc	salts	in	the	nasal	
cavity	 (Vakili	 et	al.,	2009).	For	 instance,	 the	administration	of	 zinc	





been identified as an inhibitor of retrovirus reverse transcriptases 
with	zinc	cations	displacing	magnesium	ions	from	HIV-1	RT,	thereby	








8  | THER APEUTIC ROLE OF ZINC
The	application	of	zinc	as	a	drug	to	treat	diseases	is	increasing	due	to	
advances	in	the	understanding	of	modulatory	roles	of	zinc	in	mam-
malian	 systems.	Reported	beneficial	 effects	of	 zinc	 administration	
include	reduction	in	the	incidence	of	diarrhea	and	pneumonia,	and	





reported	 to	prevent	stunted	growth	 in	children	 (Tran	et	al.,	2011).	
Zinc	has	been	found	to	be	very	useful	in	the	management	of	acute	
childhood	diarrhea	with	a	recommendation	of	10-	to	14-day	course	
of	 zinc	 treatment,	 in	addition	 to	 the	usual	 administered	oral	 rehy-
dration	solution,	by	the	World	Health	Organization	and	the	United	
Nations	Children's	Fund	(Patel	et	al.,	2011).	Zinc	has	been	used	ther-






of	zinc	 in	many	clinical	diseases.	More	 importantly,	 the	usefulness	
of	zinc	as	an	antiviral	agent	 for	 the	management	of	 such	viral	dis-
eases	as	influenza,	rhinovirus,	and	coronaviruses	strongly	suggests	
potential	beneficial	roles	and	applications	of	zinc	in	the	management	
of	COVID-19,	 probably	 through	 the	 enhancement	 of	 the	 total	 an-
tioxidant	 capacity	 and	 immunomodulatory	 effects.	 Therefore,	 the	








the	 host	 cell.	 Hence,	 zinc	 supplementation	 could	 be	 of	 potential	
benefit	 for	 mitigating	 COVID-19	 that	 has	 brought	 unprecedented	
global	health	crises	and	economic	burden.	In	the	current	pandemic	
of	 COVID-19,	 zinc	 supplementation	 could	 play	 significant	 roles	 in	
the	fight	against	COVID-19	as	immune	booster	with	anti-viral	drugs	
and	 inhibiting	 SARS-CoV-2	 replication	 in	 infected	 cells	 especially	
if	combined	with	chloroquine	and	anti-inflammatory	drugs	such	as	
dexamethasone	by	preventing	the	release	of	pro-inflammatory	cy-








insight in containing the unprecedented global health crisis and eco-
nomic	catastrophe	created	by	COVID-19	pandemic.
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